Studies on osteosarcoma have shown that downregulation of YY1 negatively regulates the VEGF/CXCR4 axis pathway, thereby inhibiting angiogenesis and tumor cell migration by reducing the transcription and activity of MMPs [41,42]. The gene discussed is YY1; the disease is neoplasm.